title: Low-molecular-weight dextran infusion is more effective for the treatment of hemoconcentration due to severe ovarian hyperstimulation syndrome than human albumin infusion.
abstract: The most severe complication of ovarian hyperstimulation syndrome (OHSS) is thromboembolism, which is related to hemoconcentration. Dextran 40 infusion has greater effectiveness for the treatment of hemoconcentration due to OHSS than does human albumin infusion.
authors.affiliation: Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Sapporo, Japan. endot@sapmed.ac.jp
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Endo
authors.forename: Yoshimitsu
authors.initials: Y
authors.lastname: Kitajima
authors.forename: Takuhiro
authors.initials: T
authors.lastname: Hayashi
authors.forename: Miho
authors.initials: M
authors.lastname: Fujii
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Hata
authors.forename: Atsushi
authors.initials: A
authors.lastname: Azumaguchi
mesh_terms: D000328:Adult; D003911:Dextrans / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000097:blood* / Q000188:drug therapy*; D010952:Plasma Substitutes / Q000627:therapeutic use*; D012709:Serum Albumin / Q000627:therapeutic use*
chemical_list: D003911:Dextrans; D010952:Plasma Substitutes; D012709:Serum Albumin